How Dogan was paid
$312,300 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Other | Total |
|---|---|---|---|
| Meeshanthini V. DoganCEO | $300,000 | $12,300 | $312,300 |
| Warren HosseinionChairman | $300,000 | $0 | $300,000 |
| Elisa LuqmanCFO | $275,000 | $0 | $275,000 |
| Timur DoganCTO | $250,000 | $10,300 | $260,300 |
What changed and why
- $312K$312,300 was the CEO's total compensation in 2025 versus $1,315,656 in 2024.
- 0 annual bonuses were awarded to named executive officers in 2025 or 2024.
- 0 named executive officers received stock option grants in 2025.
- $300K$300,000 was the CEO's 2025 base salary under her employment agreement.
- $12,300$12,300 of the CEO's other compensation included 401(k) contributions and health and dental insurance coverage.
Other Cardio Diagnostics Holdings proxy statements
- 2025 proxy statement
Meeshanthini V. Dogan paid $1.3M (+103% on the year).
Filed Sep 04, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.